Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2007-12-31
2020-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Stress Echocardiography in the Detection of Pulmonary Arterial Hypertension in Systemic Sclerosis Patients
NCT01202045
Non-Invasive Diagnostic and Functional Evaluation of Cardiac Involvement in Patients With Systemic Sclerosis
NCT00453752
Cardiac Repercussion of Systemic Sclerodermias
NCT00697736
Cross-sectional Study of Use of Speckle Method in Early Diagnosis of Cardiovascular Dysfunction
NCT02132585
Cardiac Speckle Tracking Myocardial Strain Balance
NCT03464591
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Significant valvular disease
* Low left ventricular function upon echocardiography (ejection fraction\<55%)
* History of atrial fibrillation, myocardial infarction, pulmonary thromboembolisms, neoplasia or severe hepatic disease.
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondazione IRCCS Policlinico San Matteo di Pavia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Carlomaurizio Montecucco
Director, Dept. of Rheumatology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stefano Ghio, MD
Role: STUDY_DIRECTOR
IRCCS Foundation Policlinico S. Matteo, Cardiology
Lorenzo Cavagna, MD
Role: PRINCIPAL_INVESTIGATOR
University and IRCCS Foundation Policlinico S. Matteo, Rheumatology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IRCCS Foundation Policlinico S. Matteo
Pavia, PV, Italy
IRCCS Policlinico S. Matteo
Pavia, PV, Italy
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Cavagna L, Caporali R, Klersy C, Ghio S, Albertini R, Scelsi L, Moratti R, Bonino C, Montecucco C. Comparison of brain natriuretic peptide (BNP) and NT-proBNP in screening for pulmonary arterial hypertension in patients with systemic sclerosis. J Rheumatol. 2010 Oct;37(10):2064-70. doi: 10.3899/jrheum.090997. Epub 2010 Jul 15.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EchostressSSc
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.